Prevalence of breakthrough in chronic hepatitis C patients undergoing antiviral therapy: role of type and schedule of alpha interferon C.H.S.G

J Hepatol. 1997 Feb;26(2):449-50. doi: 10.1016/s0168-8278(97)80069-4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / administration & dosage*
  • Chronic Disease
  • Drug Administration Schedule
  • Hepatitis C / therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage*
  • Recombinant Proteins

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins